Invention Grant
- Patent Title: Protein kinase inhibitors
- Patent Title (中): 蛋白激酶抑制剂
-
Application No.: US12977197Application Date: 2010-12-23
-
Publication No.: US08278297B2Publication Date: 2012-10-02
- Inventor: Jean-Damien Charrier , Steven Durrant
- Applicant: Jean-Damien Charrier , Steven Durrant
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Andrew N. Weber; Jonathan P. O'Brien
- Main IPC: C07D475/12
- IPC: C07D475/12 ; C07D487/04 ; A61K31/519
Abstract:
In one aspect, the invention provides compounds of Formula I or pharmaceutically acceptable salts thereof. In another aspect, the invention provides methods for treatment of diseases or disorders mediated by a protein kinase, comprising administering a therapeutically effective amount of a compound of this invention.
Public/Granted literature
- US20120028966A1 PROTEIN KINASE INHIBITORS Public/Granted day:2012-02-02
Information query
